In a press release issued after market hours on February 20, Cipla said the approval covers Nilotinib capsules in 50 mg, 150 mg, and 200 mg strengths. The oncology drug, administered orally ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces for U.S. President Donald Trump's plans to tax pharmaceutical imports.

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...